A strategy for erythropoietin treatment in myelodysplastic syndromes.
Hast
R
R
Department of Medicine, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden. robert.hast@kids.ki.se
D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000503:physiopathology
D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor